Novum Peptides

Research use only

Before you enter

Please confirm the following before browsing Novum Peptides.

Adults onlyYou must be 18 years or older to enter.

Laboratory research onlyOur products are not for human or veterinary use.

We’ll remember your confirmation on this browser where storage is available.

Novum Peptides · For laboratory research only

Insertion sequences and misincorporated residues

Distinguish an extra amino-acid residue from replacement by a different one, and understand why chain length and intact mass cannot resolve every sequence error.

An insertion adds material to the intended peptide sequence. A misincorporated residue can instead replace the intended building block with a different one. Both are sequence-identity problems, but they are not interchangeable: one can lengthen the chain while the other can preserve its length.

Separate addition from replacement

Illustrative sequence errors
SequenceRelationship to Ala-Ser-Leu
Ala-Ser-Ser-LeuOne additional serine
Ala-Thr-LeuThreonine replaces serine
Ala-Ser-IleIsoleucine replaces leucine
Ala-LeuSerine is missing; this is a deletion

The examples are invented and assume the same termini. They show why a statement that a peptide has the correct number of residues cannot establish its sequence: both substituted three-residue examples retain the target's length.

The EMA guideline describes insertion formation when an amino acid is coupled more than once in an intended coupling step. It also identifies starting-material impurities as a possible source of incorrect building blocks entering the final sequence.EMA — Sequence-related synthetic peptide impurities (opens in a new tab)

An extra addition is not the same as deliberately repeating a coupling

The intended purpose of repeating a coupling operation can be to complete the same planned addition on chains that have not reacted. That process description is different from a molecular product that contains two copies where only one was intended. Do not diagnose an insertion simply because a method mentions a repeated coupling.

Insertion formation depends on which reactive species and available sites are actually present. The EMA discussion includes premature deprotection or residual amino-acid derivative among the possible contributing circumstances. Those are possibilities, not a retrospective diagnosis from an isolated chromatogram.EMA — Sequence-related synthetic peptide impurities (opens in a new tab)

A 2019 soluble-tag-assisted synthesis study reported a modified approach intended to avoid double additions during sequential operations. It provides a specific example of a process design addressing insertion risk, without demonstrating that every material made by that broad method is insertion-free.Improved Tag-Assisted Liquid-Phase Peptide Synthesis (opens in a new tab)

Some substitutions preserve elemental mass

Leucine and isoleucine provide a useful limit case. They differ in side-chain connectivity but have the same elemental composition. Replacing one with the other in an otherwise identical peptide therefore leaves the intact molecular mass unchanged.

This differs from the Ala-Thr-Leu example, where replacing serine with threonine changes composition. A mass difference can help flag some substitutions, but absence of a difference does not exclude all of them. The measurement's resolving power cannot separate two exactly equal elemental masses by mass alone.

For repeated identical residues, an insertion's exact history can also remain unclear. Adding one glycine within a run of glycines can produce the same final residue string regardless of which identical position is described as the extra addition.

Describe the observed difference without overstating its cause

A useful impurity record states the proposed sequence, the supporting evidence and any unresolved positions. Distinguish a directly established residue replacement from a nominal mass change merely consistent with one candidate. Keep stereochemical assignments explicit when they have been measured.

The same discipline applies to provenance. An incorrect final residue could be consistent with a building-block problem, but the final sequence alone may not reveal when or why the difference arose. A source-specific process conclusion needs source-specific process evidence.

  • Classify the change as addition, replacement or omission.
  • Check whether residue count actually changes.
  • Consider isobaric substitutions when intact mass matches.
  • Preserve the confidence level of the sequence assignment.

Sources and further detail

  1. EMA — Sequence-related synthetic peptide impurities (opens in a new tab)

    Final guideline section 4.3.2, effective 1 June 2026. Used for insertion and starting-material impurity concepts, not legal advice or product compliance.

  2. Improved Tag-Assisted Liquid-Phase Peptide Synthesis (opens in a new tab)

    Organic Process Research & Development 23, 2576–2581 (2019). Primary icatibant-acetate process example addressing double additions; no operating recipe or general purity promise.

Sources checked 19 September 2026. Worked examples are illustrative unless a supplied report is explicitly identified. This article has not undergone independent scientific peer review.